| Descriptor English: | Paraneoplastic Cerebellar Degeneration | ||||||
| Descriptor Spanish: |
Degeneración Cerebelosa Paraneoplásica
| ||||||
| Descriptor Portuguese: | Degeneração Paraneoplásica Cerebelar | ||||||
| Descriptor French: | Dégénérescence cérébelleuse paranéoplasique | ||||||
| Entry term(s): |
Anti Yo Associated Paraneoplastic Cerebellar Degeneration Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration Cerebellar Degeneration, Paraneoplastic Cerebellar Syndrome, Paraneoplastic Cerebellar Syndromes, Paraneoplastic Degeneration, Paraneoplastic Cerebellar Paraneoplastic Cerebellar Degeneration, Anti Yo Associated Paraneoplastic Cerebellar Degeneration, Anti-Yo-Associated Paraneoplastic Cerebellar Syndrome Paraneoplastic Cerebellar Syndromes |
||||||
| Tree number(s): |
C04.588.614.550.650 C04.730.856.650 C10.228.140.252.620 C10.574.781.700 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D020362 | ||||||
| Scope note: | Cerebellar degeneration associated with a remote neoplasm. Clinical manifestations include progressive limb and GAIT ATAXIA; DYSARTHRIA; and NYSTAGMUS, PATHOLOGIC. The histologic type of the associated neoplasm is usually carcinoma or lymphoma. Pathologically the cerebellar cortex and subcortical nuclei demonstrate diffuse degenerative changes. Anti-Purkinje cell antibodies (anti-Yo) are found in the serum of approximately 50% of affected individuals. (Adams et al., Principles of Neurology, 6th ed, p686) |
||||||
| Annotation: | coord with precoord organ/neopl term + histol type |
||||||
| Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
| Previous Indexing: |
Cerebellar Ataxia (1975-1999) Paraneoplastic Syndromes (1980-1999) |
||||||
| Public MeSH Note: | 2000 |
||||||
| History Note: | 2000 |
||||||
| Entry Version: | PARANEOPL CEREBELLAR DEGENERATION |
||||||
| DeCS ID: | 34185 | ||||||
| Unique ID: | D020362 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2000/01/01 | ||||||
| Date of Entry: | 1999/11/04 | ||||||
| Revision Date: | 2009/07/06 |
-
-
DISEASES
Neoplasms [C04]Neoplasms -
DISEASES
Neoplasms [C04]Neoplasms
|
|
Paraneoplastic Cerebellar Degeneration
- Preferred
Paraneoplastic Cerebellar Degeneration, Anti-Yo-Associated
- Narrower
| Concept UI |
M0328227 |
| Scope note | Cerebellar degeneration associated with a remote neoplasm. Clinical manifestations include progressive limb and GAIT ATAXIA; DYSARTHRIA; and NYSTAGMUS, PATHOLOGIC. The histologic type of the associated neoplasm is usually carcinoma or lymphoma. Pathologically the cerebellar cortex and subcortical nuclei demonstrate diffuse degenerative changes. Anti-Purkinje cell antibodies (anti-Yo) are found in the serum of approximately 50% of affected individuals. (Adams et al., Principles of Neurology, 6th ed, p686) |
| Preferred term | Paraneoplastic Cerebellar Degeneration |
| Entry term(s) |
Cerebellar Degeneration, Paraneoplastic Cerebellar Syndrome, Paraneoplastic Cerebellar Syndromes, Paraneoplastic Degeneration, Paraneoplastic Cerebellar Paraneoplastic Cerebellar Syndrome Paraneoplastic Cerebellar Syndromes |
| Concept UI |
M0335813 |
| Preferred term | Paraneoplastic Cerebellar Degeneration, Anti-Yo-Associated |
| Entry term(s) |
Anti Yo Associated Paraneoplastic Cerebellar Degeneration Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration Paraneoplastic Cerebellar Degeneration, Anti Yo Associated |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
